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Juxtaglomerular body abnormalities in youth-onset diabetic subjects.
Abnormal microalbuminuria in insulin-dependent diabetic subjects
(IDDS) is significantly associated with pre-clinical nephropathy. In
youth-onset IDDS declining plasma renin activity is significantly asso-
ciated with improved albumin excretion, while persistently elevated
renin activity is associated with continued abnormal microalbuminuria.
To determine if these changes are reflected in changes in cell count in
the juxtaglomerular body and if biopsy findings correlate with abnormal
microalbuminuria, renal tissue of 20 IDDS (Study IDDS) ages 16 to 31
years, evaluated concurrently for plasma renin activity and microalbu-
minuria, were examined by light microscopy. Biopsy or autopsy
specimens from 21 normal subjects and 32 IDDS (Non-Study IDDS),
ages 2 to 25, were also examined. Specimens from the majority of
prepubertal and all pubertal and postpubertal Non-Study IDDS and all
Study IDDS independently of status of microalbuminuria had morpho-
logic abnormalities. Normal or mesangially expanded glomeruli were
found in association with expanded juxtagomerular bodies and in-
creased cell number, or with sclerotic bodies and decreased cell
number. Sclerosis ofjuxtaglomerular bodies occurred independently of
glomerular sclerosis. The highest percentage of glomeruli with ex-
panded juxtaglomerular bodies and high cell count was present in
specimens of Study IDDS with the most abnormal levels of microalbu-
minuria, T lymphocytes, noted within juxtaglomerular bodies, were
present in specimens of 62% of the 52 Study and Non-Study IDDS.
Abnormalities of the juxtaglomerular body are distinctive features of
renal pathology in IDDS. T lymphocytes in the endocrine juxtaglomer-
ular body suggest the presence of an autoimmune process. Confirma-
tory studies are necessary.
In 1935 Kimmeistiel and Wilson [1] called attention to renal
lesions in insulin-dependent diabetic subjects with their descrip-
tion of nodular glomeruloscierosis. Diffuse glomerulosclerosis,
described in the 1950's, occurs more frequently and is charac-
terized by increased mesangial matrix and thickened glomerular
basement membranes.
The few published studies of the juxtaglomerular body in
diabetic subjects came later and are limited to older adults.
Schindler and Sommers [2] in 1966 reported sclerosis and
reduced cell number in the juxtaglomerular body in the pres-
ence of diabetic nephropathy. Bader and Meyer [31 noted
enlarged juxtaglomerular bodies in fifty renal biopsies from
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adult diabetic subjects with nodular or diffuse glomerulosclero-
sis but gave no data on the cells. Rasch and Holck [4] reported
a 38% increase in contact area between the macula densa and
the juxtaglomerular body in the diabetic rat associated with an
increase in glomerular volume of similar magnitude.
In a prospective study among fifty youth-onset insulin-depen-
dent diabetic subjects ages 13 to 20 years at the time of initial
study [5], we reported high plasma renin activity in 43% of the
group, low in 12% and normal in 45%. Over the three to eight
year period of study, the percentage of those with high activity
fell to 13%, with low activity rose to 35% and with normal
activity rose to 52%.
In order to determine lithe heightened plasma renin activity
and the decline to low activity had morphologic counterparts in
the juxtaglomerular body and its cells, eighteen subjects of the
IDDS under study, now 18 to 31 years of age, and two studied
for the first time, underwent renal biopsy. Renal function and
plasma renin activity were assessed just prior to biopsy.
Methods
Renal tissue was obtained from biopsy specimens of 20 IDDS
16 to 31 years of age at the time of evaluation of renal function,
measurement of plasma renin activity and urinary microalbu-
minuna (Study IDDS).
Renal tissue from autopsy specimens of 21 non-diabetic
subjects ages 2 to 25 years were examined to establish norma-
tive values for total glomerular area, juxtaglomerular body area
and cell number in childhood through young adulthood. Causes
of death included accidental death, meningitis, staphylycoccal
septicemia and subaortic stenosis in otherwise healthy subjects.
Renal tissue from autopsy and biopsy specimens from 32
youth-onset diabetic subjects, ages 2 to 25 years (Non-Study
IDDS), with known age of onset, course and duration of
diabetes were examined for comparison with findings in the
normal subjects and in the Study IDDS. The autopsy specimens
were obtained from six diabetic subjects ages 2 to 14 years and
one 23-year-old adult, with causes of death diabetic coma alone
or associated findings of cerebral edema or sarcoma of the
pencardium; the biopsy specimens were obtained from 26
diabetic subjects ages 9 to 25 years who had no other health
problems.
Tissue was either fixed in 10% formalin for paraffin embed-
ding or snap frozen and stored at —70°C. Hematoxylin-eosin
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stained slides were examined by light microscopy, visualized on
the screen of the Bioquant System IV® (R and M Biometrics,
Nashvffle, Tennessee, USA) and measurements of glomerular
and juxtaglomerular body areas and cell counts made at mag-
nifications of 25 x and 40 x. Measurements were made only in
glomeruli containing a juxtaglomerular body, stalk and macula
densa, giving comparable sagittal sections. Data were recorded
on a high capacity formated disc for retrieval and calculations.
Four micron paraffin sections were processed for immuno-
peroxidase staining using an avidin-biotin-peroxidase complex
method and 3,3' diaminobenzidine substrate [6]. Frozen tissues
from renal biopsies in the 20 Study IDDS were cut at 4 microns
and stained using the same methodology. Appropriate positive
and negative control sections were used [7]. The antibodies
used in staining the paraffin sections were the B lymphocyte
marker L26 and the T lymphocyte markers CD3 and UCHL- 1.
T lymphocyte subsets were identified in frozen sections using
CD4 for helper T cells and CD8 for suppressor T cells. The
macrophage marker MAC 397 was used (Dako Corporation,
Carpiuteria, California, USA).
Glomerular filtration rates were measured by plasma disap-
pearance of the radionuclide diethylenetriamine pentaacetic
acid (99mTC) [8] with the subject in the supine position. Glomer-
ular ifitration rates, significantly associated with % hemoglobin
A!, were evaluated after adjustment for the level of glycemic
control [9]. Plasma renin activity, determined by the method of
Sealey and Laragh [10], was measured from a sample obtained
after arising and after walking quietly for three hours. Plasma
renin activity was defined as high, normal or low based on
urinary sodium excretion during the 24 hours spanning the
measurement of renin activity. Hemoglobin Al was measured
by cation exchange [11] using a kit from ho Rad, Incorporated
(Richmond, California, USA). Excretion rates of albumin were
measured during a graded exercise test [5] by radioimmunoas-
say using a kit from Diagnostic Products Corporation (Los
Angeles, California, USA). It has been determined that albumin
excretion rates during exercise, but not at rest, are significantly
associated with glycemic control [5]. Therefore, only subjects
with excretion rates calculated to be greater than the contribu-
tion made by the percent Hemoglobin A! are included in
Albumin Excretion Rate Group 2.
Statistical analyses were performed using Fisher's exact test,
Student's t statistic and regression analysis [12]. All values are
give as the mean SD.
The study was approved by the Human Investigation Com-
mittee of the University of Virginia Medical Center. Consents
for biopsies were obtained from parents of subjects under 18
years of age, and from subject themselves who were 18 years of
age or older.
Results
Renal specimens of normal and diabetic subjects had sagittal
sections present in 16% of a mean of 14.0 7.7 glomeruli in
biopsy specimens and in 5% of a mean of 337 117 glomeruli
in autopsy specimens. Total glomerular areas in specimens
from normal subjects showed significant increases from prepu-
bertal to pubertal, and pubertal to postpubertal subjects (Table
1, Fig. 1 A-C). Juxtaglomerular body areas and their cell
numbers in postpubertal subjects were similar to those in
Table 1. Measurements in biopsy/autopsy specimens of normal
subjects
Age N
Glomerular
area u2 xio
Juxtaglom
Areau2
erular
Cells
N
Prepubertal <11 7 13.4 2.1 499 163 9 2
Pubertal 11—14 4 18.0 3.8 609 120 11 2
Postpubertal >14 10 22.7 3.3 715 1% 12 3
Prepubertal vs. pubertal, P < 0.025 0.05 0.05
Pubertal vs. postpubertal, P <
Prepubertal vs. postpubertal, P <
0.025
0.05 0.05 0.05
pubertal subjects, but each were significantly greater than those
in prepubertal subjects.
Findings in renal tissue of the 32 Non-Study IDDS
In autopsy specimens from two prepubertal diabetic subjects,
a 2-year-old with new onset diabetes and a 9-year-old with four
years duration of diabetes, all glomeruli were normal. In
autopsy specimens of four prepubertal subjects mesangially
expanded glomeruli with enlarged juxtaglomerular bodies and
increased cell number were present in percentages directly
associated with duration of diabetes (P < 0.001) extending from
12% in a 3-year-old with two weeks duration of diabetes to 86%
in a 10-year-old with seven years duration.
Measurements in specimens from 6 prepubertal, 4 pubertal
and 22 postpubertal diabetic subjects (Table 2) revealed: (1) the
percentage of glomeruli of normal size and morphology was
highest among prepubertal subjects compared to pubertal and
postpubertal subjects; (2) glomeruli of normal size and morphol-
ogy, mesangially expanded glomeruli with or without sclerotic
changes could be associated with expanded juxtaglomerular
bodies containing abnormally high cell counts, or, in predomi-
nantly postpubertal IDDS, with sclerotic juxtaglomerular bod-
ies with reduced cell count; all combinations often occurred in
the same specimen; (3) glomeruli of normal size and morphol-
ogy were seen in combination with sclerotic juxtaglomerular
bodies with reduced cell number in five postpubertal subjects;
(4) sclerotic glomeruli or hyalinized glomeruli were first noted in
tissue of postpubertal subjects; (5) mild to moderate degrees of
diffuse glomeruloscierosis appeared after 5 2 years of post-
pubertal duration of diabetes, severe after 11 2 years; (6)
hyalinized glomeruli, first seen in a subject age 17, occurred in
specimens of 4 out of 18(22%) postpubertal subjects and ranged
from 18 to 43% of total glomeruli. These glomeruli also showed
varying degrees of arteriolar sclerosis, tubular atrophy, inter-
stitial fibrosis and focal lymphocytic infiltration. Electron mi-
croscopy was performed but was not helpful.
Lymphocytic infiltrates were noted adjacent to two glomeruli
in the the autopsy specimen of a 3-year-old with a two week
history of clinical diabetes. These were the only glomeruli
among 513 in the specimen that were expanded, had adjacent
lymphocytes and contained T lymphocytes (CD3) in the juxta-
glomeular bodies (Fig. 2A). T lymphocytes (CD3 and UCHL-l)
were identified in the juxtaglomerular bodies of specimens of
62% of the 32 Non-Study IDDS. MAC 387 positive macro-
phages were not identified in or about the juxtaglomerular
bodies in specimens of either control subjects or Non-Study
IDDS.
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Fig. 1. Arrows indicate the juxtaglomerular body and its cells. Normal glomeruli: (A) 5-year-old female; (B) 14-year-old male; (C) 25-year-old
female. Glomeruli in Study IDDS: (D) 22-year-old female in Group 2, expanded glomerulus, expanded juxtaglomerular body with increased cell
number; (E) 25-year-old male in Group 3, expanded glomerulus, sclerosing juxtaglomerular body, decreased cell number; (F) 28-year-old female
in Group 1, glomerulus of normal area, expanded juxtaglomerular body, increased cell number; (G) 29-year-old male in Group I, glomerulus of
normal area, sclerosing juxtaglomerular body, decreased cell number. A—C autopsy; D—G biopsy. x 200.
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Table 2. Percentage of Non-Study IDDS with specific morphologic
variations in their renal specimens
Glomerulus/Juxtaglomerular body/Juxtaglomerular
cell #
N N/N/N N/Eli E/E/I E/S/D N/S/D S/El! S/S/D
Prepubertal
<11 years 6 83 17 50 17 0 0 0
Pubertal
11—14 years 4 50 50 25 0 0 0 0
Postpubertal
15—25 years 22 18 32 32 14 23 14 18
Abbreviations are: N, normal area/normal cell number; E, expanded
area; I, increased number; S, sclerotic; D, decreased number. Glomer-
uli examined: prepubertal (autopsy 5/biopsy 1): 85; pubertal (biopsy 4):
13; and postpubertal (autopsy 1/biopsy 17): 56. N is number of subjects.
Functional studies and biopsy findings in the 20 Study IDDS
Eighteen of the 20 subjects, age 18 to 31, who underwent
functional studies at the time of renal biopsy are part of a cohort
of 100 youth-onset insulin-dependent diabetic subjects who
have been studied approximately every two years over ten
years. Two of the 20 subjects underwent their first studies at the
time of renal biopsy. Measurements of microalbuminuria at rest
and during graded exercise and plasma renin activity at rest and
after quiet ambulation were made at the time of admission for
renal biopsy. Subjects were divided into four groups based on
levels of microalbuminuria at rest and during exercise [5] (Table
3) with the following albumin excretion rates: Group 1, normal
levels at rest (range 0.5 to 7.0 pg/min/M2) mean SD, 2.7 2.6,
and during exercise (1.1 to 11.0) 5.0 3.6; Group 2, normal at
rest (0.6 to 2.6) 1.6 1.0, and abnormally elevated rates only
during exercise (43 to 53) 49.7 5.8; Group 3, abnormally
elevated rates at rest (18 to 125) 47.1 47.0, and during
exercise (18 to 270) 81.0 85.8; and Group 4, abnormally
elevated levels at rest and during exercise equal to or greater
than 150 /Lg/min/M2. There were no differences among the four
groups in respect to age, age of onset of diabetes or level of
glycemic control as measured by Hemoglobin Al. Glomerular
ifitration rates were greater than normal in subjects in Groups 1
to 3 but within normal limits when corrected for percent
Hemoglobin Al (%HbAI) [9]. Subjects in Group 3 had a
significantly higher mean blood urea nitrogen (F> 0.05) than
those in Groups 1 and 2, but all had normal serum creatinine.
The two subjects in Group 4 had markedly diminished glomer-
ular filtration rates and high levels of blood urea nitrogen and
creatinine.
Blood pressures taken in the sitting position at the time of
admission for renal biopsy were within normal limits for age in
all subjects in Groups 1 and 2 (females, 102 to 110, 106 4/66
to 80, 72 6; males, 100 to 124, 114 8/60 to 82, 74 8). In
Group 3, systolic pressures were normal in all subjects (fe-
males, 110 to 120, 116 6; males 110 to 122, 116 6). Three
males andone female had normal diastolic pressures, 68, 70, 76,
and 76; two females and one male had elevated diastolic
pressures, 83, 87 and 98. Both subjects in Group 4 had elevated
systolic and diastolic pressures, male 140/100, female 140/90.
Plasma renin activity
Group 1. Plasma renin activity in five of the eight subjects
(3F/SM) in Group 1 was normal at entry to the study at ages 13
to 20 years. Over two to three years plasma renin activity fell to
low in all five. The sixth subject, age 30 at biopsy, had low
plasma renin activity and normal albumin excretion at entry at
age 20. Two subjects, entered at ages 18 and 19 with high
plasma renin activity and in Group 3. Within two and three
years their plasma renin activity fell to normal and they entered
Group 2. At time of biopsy, afer a total of six and seven years,
they were in Group 1 with low plasma renin activity.
Group 2. Plasma renin activity was high in two of three
subjects (lF/2M) who initially and at biopsy were in Group 2.
They maintained high activity from age 14 until ages 20 and 21.
Two years later, when renal biopsies were performed, plasma
renin activity was low. The third subject, age 31 at biopsy, had
low plasma renin activity in the initial study at age 20.
Group 3. Plasma renin activity was high in the initial study in
all seven subjects (3F14M) who were in Group 3 at the time of
biopsy. In two, ages 16 and 21, the time of biopsy constitutes
their first study. Two subjects, both age 14 and in Group 1 in the
initial study, at time of biopsy at age 18, continued to have high
activity. Plasma renin activity in the fifth subject fell to normal
between ages 21 and 23; in two subjects it fell to low, in one
between ages 17 and 18, and in the second between 22 and 25.
All three continued to be in Group 3 at the time of biopsy at ages
25, 23 and 30. In the latter subject, however, albumin excretion
rates steadily declined during the five years of low activity.
Group 4. Plasma renin activity was low in two subjects
(1Ff lM) in Group 4 at biopsy at ages 23 and 24. The male
subject in his initial study at age 17 was in Group 4 with high
activity. The female subject initially at age 18 had high activity
and was in Group 3. By age 21 she had progressed to Group 4.
Subjects in Group 4 and those in Group 3 were placed on the
alpha agonist, clonidine, after biopsy.
Biopsy results
All biopsies contained abnormal glomeruli (Fig. 1 D-G) as
described in specimens of Non-Study IDDS. In specimens of
three subjects in Group 1 and one in Group 2 glomeruli of
normal size were present in association with sclerotic juxtaglo-
merular bodies with decreased cell number (Fig. 1G). Light
microscopy revealed changes in the subjects of Groups 1 to 3
consistent with mild diabetic nephropathy. Specimens of sub-
jects in Group 4 revealed changes of severe nephropathy and a
predominance of hyalinized glomeruli, 62 and 80% of total
glomeruli, a reasonable explanation for low plasma renin activ-
ity in these two subjects. No hyalinized glomeruli were present
in specimens of subjects in Groups 1 and 2 and were present in
only two of those of the seven in Group 3, each with 25% of
total glomeruli hyalinized.
We define two categories of mesangially expanded glomeruli
present in biopsy specimens that describe the transition from
highly cellular juxtaglomerular bodies to sclerotic bodies with
few cells (Table 4). Category I defines expanded glomeruli with
expanded juxtaglomerular bodies and increased cell number.
Category II defines expanded glomeruli with sclerotic juxtaglo-
merular and decreased cell number. All subjects in Group 1 and
seven of eight in Group 2 had glomeruli in their specimens from
both categories, indicating that expanded juxtaglomerular bod-
ies with abnormally increased cell number had diminished
markedly and were replaced by sclerotic bodies with few cells.
In contrast, only three of the seven subjects in Group 3 had
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Fig. 2. Arrows indicate T lymphocytes
(brown-stained cells) in the
juxtaglomerular bodies. (A) Three-year-
old female, new onset diabetic, UCHL-1;
(B) 10-year-old male, diabetic 7 years,
UCHL-l; (C) 24-year-old. female,
diabetic 11 years, in Group 1, UCHL-l.
A, autopsy X 200; B, biopsy, X 400.
Table 3. Characteristics of Study IDDS at time of renal biopsy
GFR
AER Gp
Female/male
N
Age
years
Age at
onset
Duration
years
HbAI
%
ml/min/
1.73/rn2
S.
mg/dl
BUN
mg/dl
1 3/5 26±4 8±5 18±6 12±3 140±20 0.7±0.2 13±2
2 1/2 24±5 10±4 14±7 10±2 132±19 0.9±0.2 13±2
3 3/4 23±7 11±4 12±4 14±4 138±25 0.8±0.2 17±4
4 1/1 23,24 9,5 14, 19 12, 14 39, 32 1.6, 1.9 21,27
Normal values 6.9 0.8 111 13 0.7—1.3 10—20
Abbreviations are: AER, albumin excretion rate (see text for definition); HbAI, hemoglobin Al; GFR, glomerular filtration rate; Scr, serum
creatinine; BUN, blood urea nitrogen.
giomeruli of Category II in their specimens. No glomeruli in
Category I were present in specimens of subjects in Group 4.
Specimens from 60% of the 20 Study IDDS, all from Groups
ito 3, had T lymphocytes in the JGB that were positive for the
following antibodies: CD3, CD4, CD8 and UCHL-l (Fig. 2B).
No MAC 387 positive macrophages were identified in or about
the JOB of any biopsies of Study IDDS.
The cell surface markers used in the study were found only
rarely on cells in the mesangial, periglomerular or tubular
interstitial regions in specimens of either Study or Non-Study
IDDS.
Discussion
The juxtaglomerular body normally has 8 to 15 epitheliod
cells located near the glomerular hilus in continuity with muscle
cells of the afferent arteriole and in close proximity to the
macula densa. Goormaghtigh [13] ascribed an endocrine func-
tion to the cells which are the body's major producer of renin.
A review of the literature of studies of renal morphology in
human diabetes reveals occasional micrographs of glomeruli
with enlarged juxtaglomerular body areas and significantly
increased cell numbers but no discussion of these abnormalities
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Table 4. Biopsy data of Study IDDS, AER Groups 1 to 4
Category I Category II
n
Glomeruli
n Subjects
I n
II nn/N
Expanded
glomerular
area
Sclerotic
juxtaglomerular
AER n/N
Expanded
glomerular
area
Expanded
juxtaglomerular
Area Cells Area Cells
Group x io 2 x 1O ,2
1 8/8 33 7 2412 1370 28 11 7/8 27 4 1344 604 12 3 4.4 1.1
2 3/3 32 6 2813 690 33 9 3/3 35 1 2023 544 11 4 4.0 1.0
3 7/7 31 1 2612 1199 29 8 3/7 38 2 1897 585 10 2 4.1 2.3
4 0/2 2/2 33±7 1964±909 8±3 3.5 —
Abbreviations are: AER, albumin excretion rate. n/N, number of subjects (n) of the total number (N) whose biopsy specimen had cells in a given
Category. P < vs. normal values:
Category I
Category IIJuxtaglomerular
Glomerular Cell glomerular
Group area Area number area
1 0,01 0.001 0.001 0.05
2 0.01 0.001 0.001 0.05
3 0.001 0.001 0.001 0.05
4 0.01
([14], Fig. 6; [15], Fig. 1B; [16], Fig. 1; [17], Fig. 1). In other
studies sagittal sections of glomeruli are lacking.
Several reasons may be given to explain why little attention
has been given to the juxtaglomerular body and its cells. First,
only a small percentage of total glomeruli in renal biopsies will
have sagittal sections for measurements. Secondly, sclerosed
juxtaglomerular bodies with low cell number in association with
scierosed glomeruli are the common finding in adults with
diabetic nephropathy [2], and have been inferred to be part of a
general sclerotic process. Finally, renal pathologists may have
been diverted from its study because it was believed there were
no changes in the juxtaglomerular apparatus specific to diabetic
nephropathy [18].
The present study reveals that abnormalities of juxtaglomer-
ular body size and cell number noted in renal tissue of the
majority of prepubertal and in all pubertal and postpubertal
insulin-dependent diabetic subjects are an integral and distinc-
tive part of the renal pathology in youth-onset diabetes.
The changes in juxtaglomerular cell number strikingly paral-
lel changes in plasma renin activity previously reported in 50
diabetic subjects 13 to 20 years of age, diagnosed before age 16,
who were studied over three to eight years [5]. In contrast to the
normal course of events in which high renin activity at birth
declines rapidly and reaches adult levels by 9 years of age
[19—21], renin activity in the youth-onset diabetic subjects
increased with prepubertal duration of diabetes and decreased
with postpubertal duration of diabetes. Over the three to eight
year period high renin activity fell to normal or low levels in
87% and remained high in only 13% of the 50 member cohort. In
prepubertal Non-Study IDDS the number of expanded glomer-
uli with enlarged juxtaglomerular bodies and increased juxta-
glomerular body cell number increased directly with prepuber-
tal duration of diabetes. In specimens of both Study IDDS and
Non-Study IDDS of all age groups increased cell number in
expanded juxtaglomerular bodies as well as diminished cell
number in sclerosing juxtaglomerular bodies were observed in
association with normal or mesangially expanded glomeruli.
Thus, the data suggest that the endocrine juxtaglomerular body
of insulin-dependent diabetic subjects is affected by a process
that initially increases its renin-producing cells and plasma
renin activity, then, at a highly variable rate, diminishes cell
number and renin activity. The variable rate at which plasma
renin activity decreases is borne out by the wide range of
subject ages and number of years over which decreases were
observed.
The presence of T lymphocytes within the endocrine juxta-
glomerular bodies suggests that the process initiating renal
disease in the diabetic is autoimmune in nature. T lymphocytes
have long been noted in association with autoimmune diseases
of other endocrine organs, including the pancreas [22], thyroid
[23], adrenals [24] and hypophysis [25]. The autoimmune pro-
cess, characterized by an initial phase of hyperplasia followed
by gradual destruction of endocrine cells, has been shown to
affect pancreatic Beta cells [26], anterior pituitary [27] and
thyroid cells [28]. Morphologic changes in the juxtaglomerular
body and its cells observed in the present study, noted as early
as three years of age at onset of clinical diabetes, suggest that a
similar process is operative in diabetic subjects, initiating
hyperplasia ofjuxtaglomerular body cells with expansion of the
body, followed over time by destruction of its cells. The
absence of macrophages is consistent with a slowly progressive
process.
Staging for the proposed autoimmune process affecting the
renin-producing cells of the juxtaglomerular body and the
consequences of increased renin production may be formulated
on the basis of published data [5, 291 and those of the present
study: first, prepubertally, antibody to a component of the
renin- producing cells stimulates hyperplasia of these cells.
Consequences of enhanced production of renin are predictable
based on its ability to initiate reactions resulting in angiotensin
II production. Mesangial cells and efferent arteriolar receptors
for angiotensin II in the rat kidney are very sensitive to its
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constrictive action [30], whereas afferent arterioles are less so
[31]. Stimuli to renin secretion, even mild exercise [32], would
lead to vasoconstriction and increased renal pressure. Abnor-
mally increased renal blood flow associated with hyperglycemia
[33], common in diabetic subjects, would enhance intrarenal
pressure when efferent arteriolar constriction restricts effiux.
Intrarenal pressure, measured at rest as renal vascular resis-
tance in the cohort of 100 [5] of which the Study IDDS are a
part, correlated significantly with concurrently measured
plasma renin activity and albumin excretion rates.
Over time, increased intrarenal pressure would lead to gb-
merular expansion, trapping of macromolecules—a demonstra-
ble effect of angiotensin II [34], cellular and tissue damage;
secondly, with the onset of puberty the increasing levels of sex
hormones influence the time of onset and severity of autoim-
mune disease by modulating lymphocytic activity with T lym-
phocytes as the primary target [35].
The finding in biopsy specimens of postpubertal Non-Study
and Study IDDS of gbomeruli of normal size in association with
sclerosed juxtaglomerular bodies and decreased cell number
suggests that if the juxtaglomerular body cells are destroyed
soon enough and increased intrarenal pressure abates, ex-
panded glomeruli can return to normal size. Reversal of abnor-
mal renal morphology has been reported in cadaveric kidneys
from diabetic subjects transplanted into non-diabetic recipients
[36].
The process striking the endocrine juxtaglomerular body cells
is highly active in the teenage years of youth-onset insulin-
dependent diabetic subjects. If, as in the subjects in Group 1,
the loss of renin-producing capacity is sufficiently rapid, normal
renal function is maintained. Alternately, high renin activity
can, as in the subjects in Group 4, be associated with early
clinical nephropathy with rapid progression to serious loss of
renal function.
The finding that alpha adrenergic agonists and angiotensin
converting enzyme inhibitors specifically reduce intrarenal
pressure by suppressing the renin-angiotensin system and re-
tard glomerular damage [37, 38] supports the proposed hypoth-
esis.
Morphologic abnormalites in biopsy specimens of diabetic
subjects in Groups 1 and 2 did not correlate with the levels of
microalbuminuna at rest or during exercise and, therefore, do
not predict which diabetic subjects are at risk for development
of clinical nephropathy. In specimens of Group 3 subjects, the
predominance of glomeruli with high juxtagbomerular cell
counts compared with the diminished counts in those of Groups
1 and 2, and the high percentage of Group 3 subjects with
persistently high renin activity may indicate that these subjects
remain at high risk for progression to clinical nephropathy.
The present studies have shown that preclinical renal disease,
revealed by abnormal microalbuminuria, can begin in the early
teens of diabetic youth and may progress rapidly to clinical
nephropathy. Identification of these individuals and initiation of
preventive therapy are presently possible. It remains to be
determined if the eventual course in subjects of Group 1 can be
predicted so that early therapeutic intervention would be un-
necessary, whether subjects in Group 2 may yet progress to
Group 3 status, and how long therapeutic intervention is
required in subjects in Group 3 to prevent progression to
clinical nephropathy.
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